Beruflich Dokumente
Kultur Dokumente
(TEG)
Lowell Chambers, MD
Secondary Hemostasis (Coagulation Cascade)
CLASSIC COAGULATION CASCADE
INTRINSIC PATH (PTT) EXTRENSIC PATH (PT)
XII XIIa
XI XIa
X Xa + Va
Ca++
Prothrombin (II) Thrombin (IIa)
IX IXa + VIIIa*
V
X Xa + Va
XIII (transglutaminase)
II Thrombin
XI XIa
Ca++ XIIIa
ACIDOSIS
Impaired Clotting Factor Function
C
Impaired Platelet Function
O
A
HYPOTHERMIA G
Increased U
CNS Injuries TF Release L
DIC
HIGH ISS O
Long Bone P
Fat Embolism
Fxs A
T
H
Dilution of Clotting Y
Increased
HYPOTENSION Factors & Platelets
IVF & PRBCs
4x increased mortality
Multifactorial
4x increased mortality
Multifactorial
Waste
ALI / MSOF
Thrombosis
Hyperfibrinolysis in Trauma
Inclusion criteria:
-Hemorrhagic Shock (SBP < 90, HR > 110)
-High risk of substantial bleeding
-Within 8 hr of injury
Johansson PI, et al. Scan J Trauma, Resus, & Emerg Med 2009; 17:45.
Hemostasis Monitoring with the
TEG System
Measures entire clotting process
1950s Dr. Henry Swan & 1960s Dr. Thomas Starzl &
Hypothermic Open Heart Procedures Liver Transplantation
TEG Method
0.36 ml whole blood incubated @ 37oC in a heated, kaolin-containing cup
(after being collected in Citrate if delay in running > 3 min)
Pin is suspended into cup and connected to a detector system (torsion wire)
Formation of fibrin results in transmitted rotation from the cup to the pin
Time (min)
Kinetics
of clot
development
LY30
Percent lysis
30 minutes
after MA
FFP +
Platelets
LMWH
LMWH +
ASA
4-8 min K
Dysfunction
FFP
Hypo- K (min)
R (min) Cryoprecipitate
coagulable (deg)
Hyper- K (min)
R (min)
coagulable (deg)
MA
K
Dysfunction
Hypo- K (min)
R (min)
(deg)
MA
coagulable
ASA
Hyper- K (min)
R (min) MA
coagulable (deg)
Parameter Clot time Clot rate Maximum clot strength Clot stability
30 min LY30
MA
R TXA
ACA
EPL
K
Dysfunction
Hypo- K (min) LY30 > 7.5%
R (min)
(deg)
MA EPL > 15%
coagulable
Hyper- K (min)
R (min) MA N/A
coagulable (deg)
Johansson PI, et al. Scan J Trauma Resus Emerg Med. 2009; 17:45
Standard TEG in Massive Tranfusion
European Prospective Trial
TEG-guided patients:
- 20% VS 32% mortality
- > FFP
- > Plts
Johansson PI, et al. Scan J Trauma Resus Emerg Med. 2009; 17:45
TEG in Trauma
Differentiates different etiologies of the Coagulopathy
of Trauma
Permits ID of Hyperfibrinolysis
Johansson PI, et al. Scan J Trauma Resus Emerg Med. 2009; 17:45
RapidTEG
Tissue Factor added to Kaolin in cup
Cuts processing time by ~ 50%:
- r-TEG19.2 min to completion
- TEG 29.9 min
- Coags 34.1 min
RapidTEG
Standard
TEG Differences: R range: 0-1 min
& use ACT
U Colorado Experience
More Goal Directed Therapy LEAN Goals met c blood products needed
2nd r-TEG in OR
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
Baylor Experience
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
Baylor Experience
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
Baylor Experience
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
Baylor Approach
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
? Mt Carmel Approach
Tapia NM, Mattox KL, Suliburk J. J Trauma Acute Care Surg 2013; 74: 378-86
U Texas Approach
Sens. 82%
Spec. 53%
Sens. 49%
Spec. 87%
Wohlauer MV, Moore EE, et al. J Am Coll Surg 2012; 214: 739-46
Agarwal S, et al. Anesthesiology 2006; 105:676-83
Platelet Mapping
% Inhibition = 100 - [(MAADP or AA MAFibrin) / (MAThrombin MAFibrin) X 100]
65
60
(n 38) (n 154)
Post PCI